Neural Regeneration Research ›› 2022, Vol. 17 ›› Issue (9): 1875-1880.doi: 10.4103/1673-5374.335691

Previous Articles     Next Articles

Emerging roles of circular RNAs in retinal diseases

Aneliya Hanineva1, Karen Sophia Park1, Joshua J. Wang1, Margaret M. DeAngelis1, 2, Michael H. Farkas1, 2, 3, Sarah X. Zhang1, 3, *   

  1. 1Department of Ophthalmology and Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA; 2Research Service, Veterans Administration Western New York Healthcare System, Buffalo, NY, USA; 3Department of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
  • Online:2022-09-15 Published:2022-03-03
  • Contact: Sarah X. Zhang, MD, xzhang38@buffalo.edu.
  • Supported by:

    This work was supported, in part, by NIH/NEI Grants EY019949, EY025061, EY030970 (to SXZ), a research grant NGR G2019302 from the Brightfocus Foundation (to SXZ), and an Unrestricted Grant from Research to Prevent Blindness to the Department of Ophthalmology, the State University of New York at Buffalo.

Abstract: Retinal disorders are a group of ocular diseases whose onset is associated with a number of aberrant molecular and cellular processes or physical damages that affect retinal structure and function resulting in neural and vascular degeneration in the retina. Current research has primarily focused on delaying retinal disease with minimal success in preventing or reversing neuronal degeneration. In this review, we explore a relatively new field of research involving circular RNAs, whose potential roles as biomarkers and mediators of retinal disease pathogenesis have only just emerged. While knowledge of circular RNAs function is limited given its novelty, current evidence has highlighted their roles as modulators of microRNAs, regulators of gene transcription, and biomarkers of disease development and progression. Here, we summarize how circular RNAs may be implicated in the pathogenesis of common retinal diseases including diabetic retinopathy, glaucoma, proliferative vitreoretinopathy, and age-related macular degeneration. Further, we explore the potential of circular RNAs as novel biomarkers and therapeutic targets for the diagnosis and treatment of retinal diseases.

Key words: age-related macular degeneration, circular RNA, diabetic retinopathy, glaucoma, microRNA, proliferative vitreoretinopathy, retina